Core Viewpoint - Aurora Cannabis Inc. is preparing for its annual general and special meeting of shareholders, emphasizing the importance of shareholder participation and outlining the company's progress and future goals [1][2][3]. Group 1: Meeting Details - The virtual meeting is scheduled for August 9, 2024, at 1:00 p.m. Eastern time, allowing shareholders to participate regardless of location [2]. - Shareholders will vote on critical matters for the company's growth, highlighting the company's efforts to stabilize and strengthen its balance sheet while reducing debt [2][3]. - The company reported that fiscal 2024 was its strongest year to date, indicating positive momentum in its operations [2]. Group 2: Company Strategy and Goals - The Board of Directors and management are focused on achieving positive free cash flow by the end of calendar 2024, with confidence in their team's capabilities to deliver shareholder value [3]. - The company aims to continue building value through stability and execution against its objectives, projecting a bright future for its operations [3]. Group 3: Shareholder Engagement - The Board recommends shareholders vote in favor of all director nominees and meeting resolutions, urging early voting before the deadline of August 7, 2024 [4]. - Shareholders are encouraged to read the management information circular for detailed voting instructions and meeting resolutions [4]. Group 4: Company Overview - Aurora Cannabis operates in the medical and consumer cannabis markets across Canada, Europe, Australia, and South America, with a diverse brand portfolio [6]. - The company is dedicated to high-quality cannabis products and innovation, positioning itself as a leader in the industry [6].

Here Are Top Marijuana Stocks For Cannabis Investors This JulyMarijuana stock investors are keeping watch for the next wave of momentum. With all that has taken place over the last several months, there is still a positive outlook for the future. People are starting to speculate on what is next for legal cannabis and investing in the sector. The DEA working on rescheduling and companies are trying to expand and keep up with consumer demands and establishing a dominant brand. This also puts people in place t ...

Core Viewpoint - The article discusses the potential for meme stocks to experience significant rallies, emphasizing the importance of identifying stocks with decent fundamentals that can benefit from speculative trading [1]. Group 1: Meme Stocks Overview - Meme stocks can experience rapid price increases, making it challenging to find good entry points [1]. - GameStop (GME) is highlighted as a meme stock to avoid due to its poor fundamentals and significant price drop from $62.8 to $23.7 [2]. - The focus is on identifying meme stocks that are undervalued and have the potential for a rally when bought on dips [1][2]. Group 2: Riot Platforms (RIOT) - Riot Platforms is considered undervalued with a forward P/E of 14, despite a 15% decline in stock price over the last 12 months [3]. - The company has a zero-debt balance sheet and a cash buffer of $1.3 billion, allowing for aggressive capacity expansion [3]. - Riot Platforms aims to increase its mining capacity from 12.5 EH/s to 31.5 EH/s by the end of the year, with a long-term goal of reaching 100 EH/s by 2027, potentially offering 5x to 10x returns in the next 24 to 36 months [4]. Group 3: Aurora Cannabis (ACB) - Aurora Cannabis is positioned for growth with the upcoming U.S. Presidential elections and favorable global regulations, including legalization in Germany [5]. - The company reported its sixth consecutive quarter of positive adjusted EBITDA and aims for positive free cash flow by December 2024 [6]. - Aurora Cannabis has been consolidating for nearly 12 months, indicating a potential for a breakout if business developments remain positive [5][6]. Group 4: Entera Bio (ENTX) - Entera Bio has seen a price correction from 52-week highs of $3.35 to $1.87, presenting a buying opportunity [7]. - The company focuses on oral delivery of peptides for treating conditions like osteoporosis, which affects 200 million women globally [7]. - Entera Bio has sufficient cash runway through Q3 of 2025, reducing the risk of immediate equity dilution [8].

Cannabis Investing 2024 Here Are 3 Canadian Marijuana Stocks For YouThe cannabis sector has experienced a large amount of growth over the years. From just a few legal states and global regions to now over 50% of the USA has a legal cannabis market. Yet even with all this progress the industry continues to face an uphill battle. Cannabis operators around the United States are dealing with several conflicting concerns.One is federal reform and having laws passed in favor of small batches and legend growers. T ...

Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2024 Earnings Conference Call June 20, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - CEO Simona King - CFO Conference Call Participants Matt Bottomley - Canaccord Eric Livshits - ATB Capital Markets John Zamparo - CIBC Pablo Zuanic - Zuanic Associates Operator Greetings and welcome to the Aurora Cannabis Inc. Fourth Quarter 2024 Results Conference Call. All participants will be in a listen-only mode and a question- ...

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.18 per share. This compares to loss of $1.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 161.11%. A quarter ago, it was expected that this company would post a loss of $0.10 per share when it actually produced a loss of $0.20, delivering a surprise of -100%.Over the last four quarters, the co ...

Delivers Record Annual Adjusted EBITDA1 of $12.8 Million NASDAQ | TSX: ACB Q4 Represents the Sixth Consecutive Quarter of Positive Adjusted EBITDA1 Increased Total Quarterly Net Revenue 5% YoY to $67.4 Million, Global Medical Cannabis Net Revenue1 Grew by 20% YoY to $45.6 Million Ended the Fiscal Year with a Cash Position of ~$180 Million with Cannabis Business Debt-Free2 Re-Affirms Target of Reaching Positive Free Cash Flow1 by December 31, 2024 EDMONTON, AB, June 20, 2024 /PRNewswire/ - Aurora Cannabis ...

NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2024 on Thursday, June 20, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2024 before the opening of markets th ...

"We are thrilled to bring premium resin cartridges to the Australian market, a signal of our commitment to expanding patient access to an even greater variety of premium cannabis," said Kristin Viccars, Interim Managing Director, MedReleaf Australia. "Our products are designed with the highest standards of quality with safety in mind, and we are confident that Australian patients will value the unique experience our cartridges offer. We continue to look at new opportunities to expand our portfolio and patie ...

Short-squeeze moves can be ferocious and are perfect for investors seeking quick trading gains. With the possibility of a rate cut-induced rally, I am bullish on some short-squeeze stocks for the next few quarters.I am a long-term investor. However, I don’t shy away from taking trading positions in 5% to 10% of my fund allocation towards equities. When there are some clear short-squeeze opportunities, it makes sense to make 50% or 100% gains and invest the profits in long term bets. Of course, the short-squ ...